Your browser doesn't support javascript.
loading
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.
Mahlangu, Johnny N; Lamas, Jose Luis; Morales, Juan Cristobal; Malan, Daniel R; Salek, Silva Zupancic; Wang, Michael; Boggio, Lisa N; Hegemann, Inga; Mital, Andrzej; Cardinal, Matthew; Zhu, Tong; Sun, Pengling; Arkin, Steven.
Affiliation
  • Mahlangu JN; University of the Witwatersrand, Johannesburg, South Africa.
  • Lamas JL; National Health Laboratory Service, Johannesburg, South Africa.
  • Morales JC; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Malan DR; Hospital Dr. Sótero del Río, Puente Alto, Santiago, Chile.
  • Salek SZ; Hospital Dr. Sótero del Río, Puente Alto, Santiago, Chile.
  • Wang M; Phoenix Pharma, Mount Croix, Port Elizabeth, South Africa.
  • Boggio LN; University Hospital Centre Zagreb, Zagreb, Croatia.
  • Hegemann I; University of Colorado Hemophilia and Thrombosis Center, Aurora, Colorado, USA.
  • Mital A; Rush Hemophilia and Thrombophilia Center, Chicago, Illinois, USA.
  • Cardinal M; Haemophilia Comprehensive Care Center, University Hospital, Zurich, Switzerland.
  • Zhu T; Medical University of Gdansk, Gdansk, Poland.
  • Arkin S; Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
Br J Haematol ; 200(2): 229-239, 2023 01.
Article in En | MEDLINE | ID: mdl-35999026

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sex Chromosome Disorders / Hemophilia A Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Type: Article Affiliation country: South Africa

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sex Chromosome Disorders / Hemophilia A Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Type: Article Affiliation country: South Africa